All News - Eli Lilly and Company
Lilly's latest press releases, stories, news resources and more.
Lilly.com | Eli Lilly and Company
Dec 17, 2024 · Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
Eli Lilly and Company (LLY) Latest Stock News & Headlines
Get the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions.
Eli Lilly and Company (LLY) Latest Press Releases & Corporate News …
Get the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions.
Lilly announces $3 billion expansion of its recently acquired ...
Dec 5, 2024 · Lilly will use advanced automation, including guided vehicles, robotics and production equipment, to accelerate medicine production. From data management to operations, digital automation will be embedded throughout the site to accelerate processes and increase accuracy, allowing employees to focus on making safe, high-quality medicines.
News Release - Eli Lilly and Company
May 13, 2022 · Lilly is committed to helping people access the medicines they are prescribed and will work with insurers, health systems and providers to help enable patient access to Mounjaro. Lilly plans to offer a Mounjaro savings card for people who qualify.
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high ...
Nov 18, 2024 · For further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events ...
Lilly.com | Eli Lilly and Company
Nov 19, 2024 · INDIANAPOLIS , Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge , M.D., Ph.D. is retiring from his role as an independent director of Lilly's board of directors effective Aug. 31, 2024 .
Lilly hits record high after Mounjaro fuels forecast raise, rival data
Aug 8, 2023 · Eli Lilly on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares soaring 18% to a record...
FDA says tirzepatide shortage is over after taking a second look - NBC News
Dec 19, 2024 · The Food and Drug Administration said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly’s diabetes and weight loss drugs ...